What is a stock summary page? Click here for an overview.
Business Description
Cassava Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US14817C1071
Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.93 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -54.5 | |||||
| 3-Year EPS without NRI Growth Rate | -66.4 | |||||
| 3-Year FCF Growth Rate | -23.6 | |||||
| 3-Year Book Growth Rate | -21.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.29 | |||||
| 9-Day RSI | 33.23 | |||||
| 14-Day RSI | 30.59 | |||||
| 3-1 Month Momentum % | -2.14 | |||||
| 6-1 Month Momentum % | -90.71 | |||||
| 12-1 Month Momentum % | -87.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.62 | |||||
| Quick Ratio | 11.62 | |||||
| Cash Ratio | 10.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -16.97 | |||||
| ROA % | -13.06 | |||||
| ROIC % | -399.53 | |||||
| 3-Year ROIIC % | 4866.99 | |||||
| ROC (Joel Greenblatt) % | -665.34 | |||||
| ROCE % | -99.14 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 28.47 | |||||
| PB Ratio | 0.46 | |||||
| Price-to-Tangible-Book | 0.46 | |||||
| EV-to-EBIT | 0.38 | |||||
| EV-to-EBITDA | 0.38 | |||||
| EV-to-Forward-Revenue | 0.63 | |||||
| EV-to-FCF | 0.46 | |||||
| Price-to-Net-Current-Asset-Value | 0.54 | |||||
| Price-to-Net-Cash | 0.58 | |||||
| Earnings Yield (Greenblatt) % | 263.16 | |||||
| FCF Yield % | -172.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cassava Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.342 | ||
| Beta | -1.08 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.41 | ||
| Volatility % | 148.21 | ||
| 14-Day RSI | 30.59 | ||
| 14-Day ATR (€) | 0.095473 | ||
| 20-Day SMA (€) | 1.48645 | ||
| 12-1 Month Momentum % | -87.13 | ||
| 52-Week Range (€) | 1.0265 - 36.1 | ||
| Shares Outstanding (Mil) | 48.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cassava Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cassava Sciences Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cassava Sciences Inc Frequently Asked Questions
What is Cassava Sciences Inc(STU:PX91)'s stock price today?
The current price of STU:PX91 is €1.21. The 52 week high of STU:PX91 is €36.10 and 52 week low is €1.03.
When is next earnings date of Cassava Sciences Inc(STU:PX91)?
The next earnings date of Cassava Sciences Inc(STU:PX91) is 2025-05-09 Est..
Does Cassava Sciences Inc(STU:PX91) pay dividends? If so, how much?
Cassava Sciences Inc(STU:PX91) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers